Indraprastha Medical Corporation — 360° view

Indraprastha Medical Corporation, a company in the Hospital industry, reported revenue of ₹413 crore and net profit of ₹54 crore for the September 2026 quarter.

Indraprastha Medical Corporation (NSE: INDRAMEDCO) closed at ₹362.60 on 20 Nov 2026, down 31.7% over the past year. Its market capitalisation is ₹3,324 crore and it trades at 17.3 times earnings.

Share price
₹362.60 (20 Nov 2026)
Market cap
₹3,324 Cr (20 Nov 2026)
P/E
17.30 (20 Nov 2026)
Revenue
₹413 Cr (September 2026 quarter)
Net profit
₹54 Cr (September 2026 quarter)
ROCE
35.8% (FY26)
ROE
27.4% (FY26)
Book value
₹88.8 (FY26)
Dividend yield
1.10% (last 12 months to 20 Nov 2026)
52-week high / low
₹532.90 / ₹293.65 (20 Nov 2026)
1-year return
-31.7% (to 20 Nov 2026)
Sector
Healthcare
Industry
Hospital
Symbol
NSE: INDRAMEDCO

Incorporated in 1988 as a JV between Apollo Hospitals Enterprise Ltd. (AHEL) and the Delhi Government, Indraprastha Medical Corporation Ltd. is a super speciality tertiary care hospital in New Delhi. The Co. currently has 52 speciality departments.

Descriptive research only, not investment advice. Evenstocks is not a SEBI-registered investment adviser.